Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Numans Health Food Holdings Company Limited ( (HK:2530) ) has shared an update.
Numans Health Food Holdings warned that its profit after tax for 2025 is expected to fall sharply to no more than about RMB6.0 million, compared with approximately RMB74.9 million a year earlier. The board attributes the downturn mainly to a broad consumption downgrade in China, stronger competition from rival DHA products produced in the mainland, and an inventory impairment of around RMB19.3 million.
The company is still finalizing its 2025 results, which remain subject to review and potential adjustment before the full-year announcement due by the end of April 2026. The profit warning signals mounting operational and market pressures on the group’s China-focused health food business and underscores rising risks for shareholders and potential investors, who are urged to exercise caution when trading the stock.
More about Numans Health Food Holdings Company Limited
Numans Health Food Holdings Company Limited is a Cayman Islands-incorporated company listed in Hong Kong that operates in the health food sector. The group focuses on nutritional products, including DHA-based offerings, and generates most of its revenue from consumers in the People’s Republic of China, where it faces intensifying competition from domestic manufacturers.
Average Trading Volume: 218,181
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$590M
For an in-depth examination of 2530 stock, go to TipRanks’ Overview page.